CBD Provides Symptom Relief and Improvement in Gastroparesis

MMP News AuthorNovember 13, 2023
Pharmaceutical-grade cannabidiol (CBD) relieved symptoms in patients with idiopathic and diabetic gastroparesis and increased tolerance of liquid nutrient intake after 4 weeks of treatment in a phase 2 randomized double-blinded, placebo-controlled study recently published in Clinical Gastroenterology and Hepatology. There is “significant unmet medical need in gastroparesis,” and compared with cannabis, which has ... Read More

These are the 8 best CBD gummies you can buy, period

MMP News AuthorJuly 15, 2023
CBD’s hot streak shows no signs of cooling down any time soon, as shown by the eagerness with which consumers snap up products containing this cannabis compound. The benefits of cannabidiol create a high demand for CBD products. This results in a somewhat flooded market, which can seem like a ... Read More

These are the best CBD gummies for sleep

MMP News AuthorJuly 13, 2023
About 35% of American adults don’t get enough sleep, according to the CDC. If you are chronically sleep-deprived, you may have tried many solutions but still find getting sufficient sleep to be an elusive health goal. Raising my hand here, because I’m in the group and prescription sleeping pills are ... Read More

CBD Not Just Innocent Bystander in Weed

MMP News AuthorFebruary 13, 2023
This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. I visited a legal cannabis dispensary in Massachusetts a few years ago, mostly to see what the hype ... Read More

22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Tra…

MMP News AuthorJanuary 23, 2023
Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry /EIN News/ — BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ... Read More